FluoroPharma Medical, Inc. (FPMI)
-OTC BB 0.61 
0.02(3.17%) 1:34PM EDT
| Prev Close: | 0.63 |
|---|
| Open: | 0.61 |
|---|
| Bid: | N/A |
|---|
| Ask: | N/A |
|---|
| 1y Target Est: | 1.85 |
|---|
| Beta: | 0.11 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 0.61 - 0.63 |
|---|
| 52wk Range: | 0.51 - 1.19 |
|---|
| Volume: | 3,300 |
|---|
| Avg Vol (3m): | 23,955 |
|---|
| Market Cap: | 14.86M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | -0.19 |
|---|
| Div & Yield: | N/A (N/A) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- FLUOROPHARMA MEDICAL, INC. FinancialsEDGAR Online Financials(Tue, May 21)
- Market Trends Offer Opportunities for FPMIZacks(Mon, May 20)
- Market Trends Offer Opportunities for FPMIZacks Small Cap Research(Mon, May 20)
- FLUOROPHARMA MEDICAL, INC. Files SEC form 10-Q, Quarterly ReportEDGAR Online(Wed, May 15)
- FLUOROPHARMA MEDICAL, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and ExhibitsEDGAR Online(Mon, May 6)
- FluoroPharma Medical's CEO and Chairman, Thijs Spoor, to Present at Taglich Brothers 10th Annual Small Cap Equity Conference on May 7thMarketwired(Tue, Apr 30)
- FluoroPharma Medical To Present At Taglich Brothers 10th Annual Small Cap Equity ConferenceGlobeNewswire(Thu, Apr 18)
- ARM Holdings' Biotech Twin: FluoroPharmaat Seeking Alpha(Wed, Apr 17)
- FLUOROPHARMA MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Directors or PriEDGAR Online(Mon, Apr 15)
- FluoroPharma Announces Appointment of Dr. Joseph A. Pierro to the Board of DirectorsMarketwired(Mon, Apr 15)
- Weekly Stock Watch, Week Of 8 April 2013at Seeking Alpha(Mon, Apr 8)
- Development Momentum Accelerating in 2013Zacks Small Cap Research(Wed, Apr 3)
- FLUOROPHARMA MEDICAL, INC. Files SEC form 10-K, Annual ReportEDGAR Online(Thu, Mar 28)
- Stock Watch Wednesday, 27 March 2013at Seeking Alpha(Wed, Mar 27)
- FluoroPharma Receives Patent on Metabolic Markers for PET and SPECT ImagingMarketwired(Fri, Mar 22)
Key Statistics
| Forward P/E (1 yr): | N/A |
|---|
| P/S (ttm): | N/A |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | -0.21 |
|---|
| Quarterly EPS Est
(Mar-13)
: | -0.05 |
|---|
| Mean Recommendation*: | 1.7 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
FluoroPharma Medical, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of molecular imaging pharmaceuticals with primary applications in the area of cardiology.
View More